ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Calliditas Therapeutics to commercialize autoimmune drug in China, Singapore
June 11, 2019Torreya acted as exclusive financial advisor to Calliditas on the transaction. -
Calliditas Therapeutics signs agreement with Everest Medicines to develop and commercialize Nefecon
June 10, 2019Calliditas Therapeutics AB (“Calliditas”) and Everest Medicines II Limited (“Everest Medicines”) announced that they have entered into a license agreement to develop and commercialize Calliditas’ leading drug candidate Nefecon in Greater China and Singapo
Pharma Sources Insight January 2025
